Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Chen-Hui Luo"'
Autor:
Lu-Lu Yu, Bi-Wen Hu, Han-Xue Huang, Bing Yu, Qi Xiao, Qiao-Li Lv, Chen-Hui Luo, Cheng-Xian Guo, Jin-Gao Li, Xiao-Xue Xie, Ji-Ye Yin
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Radiotherapy (RT) is the standard treatment for nasopharyngeal carcinoma (NPC). However, due to individual differences in radiosensitivity, biomarkers are needed to tailored radiotherapy to cancer patients. However, comprehensive
Externí odkaz:
https://doaj.org/article/b9a62c77e8164bdb8ddfdae85fa24915
Autor:
Jin-Song Yan, Meng-Ying Yang, Xue-Hong Zhang, Chen-Hui Luo, Cheng-Kan Du, Yue Jiang, Xuan-Jia Dong, Zhang-Man Wang, Li-Xue Yang, Yi-Dong Li, Li Xia, Ying Lu
Publikováno v:
Cell Death and Disease, Vol 13, Iss 4, Pp 1-10 (2022)
Abstract Chronic myeloid leukemia (CML) are initiated and sustained by self-renewing malignant CD34+ stem cells. Extensive efforts have been made to reveal the metabolic signature of the leukemia stem/progenitor cells in genomic, transcriptomic, and
Externí odkaz:
https://doaj.org/article/c39a927921a745208be8808dddb3700a
Publikováno v:
Cellular Physiology and Biochemistry, Vol 46, Iss 5, Pp 1971-1984 (2018)
Background/Aims: Rap1 interacting factor 1 (RIF1) was deemed to be involved in replication timing regulation and DNA damage response. However, little is known about the role of RIF1 in malignancies. Thus, this study aimed to investigate whether the e
Externí odkaz:
https://doaj.org/article/8d7a25db972e4f1cacca4e7e5484a193
Autor:
Kun-Yan Li, PhD, Yu Qiu, MS, Yun Jiang, BS, Chen-Hui Luo, MS, Xiao-Ping Lin, BS, Jing Wang, BS, Nong Yang, MS
Publikováno v:
Current Therapeutic Research, Vol 76, Iss C, Pp 7-10 (2014)
Background: Olmesartan is an angiotensin II receptor antagonist and is effective and well tolerated in the treatment of arterial hypertension. Probenecid is a well-established hypouricemic agent for the treatment of hyperuricemia and gout. Objective:
Externí odkaz:
https://doaj.org/article/a0cab1cbc60a4725824745b54e7fb712
Autor:
Jing-Bo Peng, Chen-Hui Luo, Yi-Cheng Wang, Wei-Hua Huang, Yao Chen, Hong-Hao Zhou, Zhi-Rong Tan
Publikováno v:
Molecules, Vol 19, Iss 1, Pp 1189-1200 (2014)
A sensitive, reliable and specific LC-MS-MS method was developed and validated for the identification and quantitation of all-trans retinoic acid (ATRA) in human plasma. Acitretin was used as the internal standard (IS). After liquid-liquid extraction
Externí odkaz:
https://doaj.org/article/27948916efaf40c1abe607228a067c3d
Autor:
Minami Ohara, Harumi Takahashi, Ming Ta Michael Lee, Ming-Shien Wen, Tsong-Hai Lee, Hui-Ping Chuang, Chen-Hui Luo, Aki Arima, Akiko Onozuka, Rui Nagai, Mari Shiomi, Kiyoshi Mihara, Takashi Morita, Yuan-Tsong Chen
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105891 (2014)
UNLABELLED:To clarify pharmacokinetic-pharmacodynamic (PK-PD) factors associated with the over-anticoagulation response in Asians during warfarin induction therapy, population PK-PD analyses were conducted in an attempt to predict the time-courses of
Externí odkaz:
https://doaj.org/article/0a21cceacd444132bbc93c091cc0ed42
Autor:
Li-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, Xue-Hong Zhang, Hong-Chen Liu, Chen-Hui Luo, Yue Jiang, Zhang-Man Wang, Zhong-Yin Yang, Zhao-Peng Shi, Yi-Ci Yang, Ruo-Qu Wei, Li Zhou, Jun Mi, Ai-Wu Zhou, Zhi-Rong Yao, Li Xia, Jin-Song Yan, Ying Lu
Publikováno v:
Blood. 141:766-786
Extramedullary infiltration (EMI) is a concomitant manifestation that may indicate poor outcome of acute myeloid leukemia (AML). The underlying mechanism remains poorly understood and therapeutic options are limited. Here, we employed single-cell RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ef52b0b6b59762946845437610fac92
https://doi.org/10.1182/blood.2022017046
https://doi.org/10.1182/blood.2022017046
Autor:
Jin-Song, Yan, Meng-Ying, Yang, Xue-Hong, Zhang, Chen-Hui, Luo, Cheng-Kan, Du, Yue, Jiang, Xuan-Jia, Dong, Zhang-Man, Wang, Li-Xue, Yang, Yi-Dong, Li, Li, Xia, Ying, Lu
Publikováno v:
Cell deathdisease. 13(4)
Chronic myeloid leukemia (CML) are initiated and sustained by self-renewing malignant CD34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8dfb06e57fdc1516112596ae0286d0bf
https://pubmed.ncbi.nlm.nih.gov/35444236
https://pubmed.ncbi.nlm.nih.gov/35444236
Autor:
Hong Hao Zhou, Yan Chen, Yu Xi Tang, Chen Hui Luo, Min Zhao, Kai Ning Fang, Jing Wang, Yan Tang, Shohreh Shahabi, Xiao Yan Chen
Publikováno v:
Journal of Cancer
Human epididymis protein 4 (HE4) is one of the most promising biomarkers for epithelial ovarian cancer (EOC). The majority of previous studies utilized the serum level or tissue protein expression of HE4 based upon immunohistochemistry (IHC) to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30321278593e6b3b6ea20baadbf8089d
https://doi.org/10.7150/jca.23639
https://doi.org/10.7150/jca.23639
Autor:
Shohreh Shahabi, Jing Wang, Min Zhao, Liang Zeng, Wenan Qiang, Hong Hao Zhou, Chen Hui Luo, Xiao Yan Chen
Publikováno v:
Journal of Cancer
For recurrent ovarian cancer (ROC), secondary cytoreductive surgery (SCS) is recommended as one optional treatment. However, little is known about the expression and clinical significance of biomarkers during SCS. Human epididymis protein 4 (HE4) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99274803f770ea25d69cae2a462695aa
https://doi.org/10.7150/jca.25184
https://doi.org/10.7150/jca.25184